{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:09:45Z","timestamp":1769760585562,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005032","name":"Funda\u00e7\u00e3o Bial","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejphar.2020.173742","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T16:51:46Z","timestamp":1605718306000},"page":"173742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Opicapone enhances the reversal of MPTP-induced Parkinson-like syndrome by levodopa in cynomolgus monkeys"],"prefix":"10.1016","volume":"892","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-4686","authenticated-orcid":false,"given":"Maria Jo\u00e3o","family":"Bonif\u00e1cio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5616-9329","authenticated-orcid":false,"given":"Filipa","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcio","family":"Soares-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173742_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40262-012-0024-7","article-title":"Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor","volume":"52","author":"Almeida","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2020.173742_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2015.03.038","article-title":"Translational research for Parkinsons disease: the value of pre-clinical primate models","volume":"759","author":"Badin","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173742_bib3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","article-title":"Animal models of Parkinson's disease","volume":"279","author":"Blandini","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2020.173742_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuropharm.2013.10.014","article-title":"Brain and peripheral pharmacokinetics of levodopa in the cynomolgus monkey following administration of opicapone, a third generation nitrocatechol COMT inhibitor","volume":"77","author":"Bonifacio","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173742_bib5","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/bph.13020","article-title":"Pharmacological profile of opicapone, a third generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat","volume":"172","author":"Bonif\u00e1cio","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173742_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14740338.2018.1433659","article-title":"The launch of opicapone for Parkinson's disease: negatives versus positives","volume":"17","author":"Castro Caldas","year":"2018","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2020.173742_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9258(18)74965-X","article-title":"Spectrophotometric studies: II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin","volume":"112","author":"Drabkin","year":"1935","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173742_bib8","first-page":"493","article-title":"Neuropathology of Parkinson's disease","author":"Duda","year":"2012"},{"key":"10.1016\/j.ejphar.2020.173742_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ilar.48.4.339","article-title":"Nonhuman primate models of Parkinson's disease","volume":"48","author":"Emborg","year":"2007","journal-title":"ILAR J."},{"key":"10.1016\/j.ejphar.2020.173742_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson's disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2020.173742_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1474-4422(15)00336-1","article-title":"Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial","volume":"15","author":"Ferreira","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2020.173742_bib12","doi-asserted-by":"crossref","first-page":"e1849","DOI":"10.1212\/WNL.0000000000005557","article-title":"Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease","volume":"90","author":"Ferreira","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2020.173742_bib13","first-page":"F2065","article-title":"Evaluation of the safety and tolerability of opicapone in the treatment of Parkinson's disease and motor fluctuations: analysis of pooled phase III studies","volume":"22","author":"Gama","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejphar.2020.173742_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneumeth.2018.10.031","article-title":"Reprint of \u201cAnimal models of early-stage Parkinson's disease and acute dopamine deficiency to study compensatory neurodegenerative mechanisms\u201d","volume":"310","author":"Grandi","year":"2018","journal-title":"J. Neurosci. Methods"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2020.173742_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jnc.13593","article-title":"Genetics in Parkinson disease: mendelian versus non-Mendelian inheritance","volume":"139","author":"Hernandez","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2020.173742_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2020.173742_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/B978-0-12-381326-8.00009-0","article-title":"Problems with the present inhibitors and a relevance of new and improved COMT inhibitors in Parkinson's disease","volume":"95","author":"Kaakkola","year":"2010","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ejphar.2020.173742_bib18","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/mds.26354","article-title":"Disease-modifying strategies for Parkinson's disease","volume":"30","author":"Kalia","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2020.173742_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173742_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2018.10.001","article-title":"Inhibition of catechol-O-methyltransferase in the cynomolgus monkey by opicapone after acute and repeated administration","volume":"143","author":"Kitajima","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173742_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.870060205","article-title":"Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism","volume":"6","author":"Kurlan","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2020.173742_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neurobiolaging.2005.11.013","article-title":"Effects of aging and hormonal status on bimanual motor coordination in the rhesus monkey","volume":"28","author":"Lacreuse","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2020.173742_bib23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.173742_bib24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.bbapap.2015.01.007","article-title":"Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery","volume":"1854","author":"Lin","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2020.173742_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-381326-8.00008-9","article-title":"Catechol-O-methyltransferase inhibitors in preclinical models as adjuncts of L-dopa treatment","volume":"95","author":"Marin","year":"2010","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ejphar.2020.173742_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson's disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173742_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40265-014-0343-0","article-title":"Catechol-O-methyltransferase inhibitors in Parkinson's disease","volume":"75","author":"Muller","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2020.173742_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ana.24011","article-title":"Therapeutic prospects for Parkinson disease","volume":"74","author":"Olanow","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2020.173742_bib29","first-page":"P1236","article-title":"Evaluation of non-motor symptoms in opicapone treated Parkinson's disease patients: results from a double-blind, randomized, placebo-controlled study and open-label extension","volume":"22","author":"Oliveira","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejphar.2020.173742_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/JPRLS.S85419","article-title":"Animal models of Parkinson's disease and their applications","volume":"6","author":"Park","year":"2016","journal-title":"J. Park. Restless Legs Syndr."},{"key":"10.1016\/j.ejphar.2020.173742_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s002130100733","article-title":"L-Dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations","volume":"156","author":"Pearce","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2020.173742_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2013.09.014","article-title":"Modeling Parkinson's disease in monkeys for translational studies, a critical analysis","volume":"256","author":"Potts","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2020.173742_bib33","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/bcp.12081","article-title":"Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects","volume":"76","author":"Rocha","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173742_bib34","first-page":"S30","article-title":"Continuous dopaminergic stimulation: clinical aspects and experimental bases","volume":"17","author":"Rodriguez-Oroz","year":"2011","journal-title":"Neurol."},{"key":"10.1016\/j.ejphar.2020.173742_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0074-7742(07)82012-5","article-title":"Neuroinflammation in alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?","volume":"82","author":"Rogers","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ejphar.2020.173742_bib36","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2020.173742_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson's disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejphar.2020.173742_bib38","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.neurobiolaging.2005.08.003","article-title":"Automated video analysis of age-related motor deficits in monkeys using EthoVision","volume":"27","author":"Walton","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2020.173742_bib39","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1460-9568.2000.00988.x","article-title":"Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA","volume":"12","author":"Zeng","year":"2000","journal-title":"Eur. J. Neurosci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:48:10Z","timestamp":1757976490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920308347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":39,"alternative-id":["S0014299920308347"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173742","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opicapone enhances the reversal of MPTP-induced Parkinson-like syndrome by levodopa in cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"173742"}}